Table 2.
List of different interventions undertaken in small bowel neuroendocrine tumour patients; it lists the intervention and number of procedures undertaken.
| Intervention | No. of interventions | No. of patients |
|---|---|---|
| Total number that had primary tumour resected | 100 | 100 |
| Failed resection of primary tumour | 4 | 4 |
| No resection of primary tumour | 34 | 34 |
| Primary tumour resection plus liver resection/RFA | 14 | 14 |
| Resection of liver metastases | 48 | 37 |
| Resection of other sites of metastatic disease | 2 | 2 |
| Liver transplant | 2 | 2 |
| Carcinoid heart valve surgery | 3 | 3 |
| Further bowel resection | 3 | 3 |
| TACE/TAE | 23 | 17 |
| SIRT | 7 | 6 |
| PRRT | 19 | 16 |
| 131I-MIBG therapy | 14 | 14 |
| Radiotherapy | 2 | 2 |
| Chemotherapy | 10 | 10 |
For 131I-MIBG (iodine-131-meta-iodobenzylguanidine) and PRRT (peptide receptor radiotargetted therapy) an intervention comprised of 3-4 cycles of therapy. Each embolization was counted as a separate intervention. Heart value surgery involved tricuspid valve replacement in 2 cases, and one case had a tricuspid valve replacement plus pulmonary valvuloplasty. Abdominal radiotherapy was performed in two patients.